Gradient Denervation Technologies
Gradient aims to enhance the condition of people with pulmonary hypertension.
Gradient Denervation Technologies has raised €14M across 1 funding round from 3 investors, most recently a Series A round in Sep 2023. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€14M
€14,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2023-09
latest 2023-09
Funding by year
EUR raised per yearGradient Denervation Technologies — funding by year — interactive chart.
Data table
| Gradient Denervation Technologies — funding by year | |
|---|---|
| 2023 | €14M |
Signals
High confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-08 | Series A | €14M | Asabys Partners,Sofinnova Partners,Thuja Capital | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData